Over the last two decades, advances in drug therapy for MS have led many more people to receive active treatment for the condition. There has been a concomitant growth in understanding and evidence about the need for a preventive, risk-modifying approach to achieve the best patient outcomes.
Secondary and tertiary prevention of MS by modifying lifestyle risk factors – and providing appropriate medication where needed – now represents optimal MS management. Primary prevention is within reach, through targeted risk factor modification for those at high risk; i.e., close relatives of people with MS.
Risk factors that are amenable to modification include:
Addressing these risk factors offers the best chance of both optimal quality of life and prevention of disease progression. Also, when people are engaged and empowered, they exhibit marked reduction of depression and fatigue, both of which are associated with a worsening of the disabling disease process.
OMS offers a comprehensive, research-based, patient-centered program that empowers people to take control of their own health, improve their quality of life, and reduce the impact of the disease. With OMS, managing MS can be a satisfying experience for patients and their doctors alike.
The OMS program addresses these risk factors with: